MagForce AG is a
leader in the area of nanotechnology-based cancer treatment, and the
first company worldwide to receive European approval for a medical
product using nanoparticles. The novel therapy is available to patients
at the NanoTherm®therapy center in Germany at the
Charité-Universitätsmedizin Berlin. Additional therapy centers
throughout Germany are planned for 2012.